Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl 3-({cyclopropyl[3-(2-methoxyethoxy)-5-(3-methoxypropyl)benzyl]amino}carbonyl)-4-oxopiperidine-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1160185-08-9

Post Buying Request

1160185-08-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1160185-08-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1160185-08-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,0,1,8 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1160185-08:
(9*1)+(8*1)+(7*6)+(6*0)+(5*1)+(4*8)+(3*5)+(2*0)+(1*8)=119
119 % 10 = 9
So 1160185-08-9 is a valid CAS Registry Number.

1160185-08-9Downstream Products

1160185-08-9Relevant academic research and scientific papers

Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of tertiary alcohol-bearing piperidines

Chen, Austin,Cauchon, Elizabeth,Chefson, Amandine,Dolman, Sarah,Ducharme, Yves,Dube, Daniel,Falgueyret, Jean-Pierre,Fournier, Pierre-Andre,Gagne, Sebastien,Gallant, Michel,Grimm, Erich,Han, Yongxin,Houle, Robert,Huang, Jing-Qi,Hughes, Gregory,Juteau, Helene,Lacombe, Patrick,Lauzon, Sophie,Levesque, Jean-Francois,Liu, Susana,MacDonald, Dwight,MacKay, Bruce,McKay, Dan,Percival, M. David,St-Jacques, Rene,Toulmond, Sylvie

, p. 3976 - 3981 (2011)

The design and optimization of a novel series of renin inhibitor is described herein. Strategically, by committing the necessary resources to the development of synthetic sequences and scaffolds that were most amenable for late stage structural diversification, even as the focus of the SAR campaign moved from one end of the molecule to another, highly potent renin inhibitors could be rapidly identified and profiled.

RENIN INHIBITORS

-

Page/Page column 36-37, (2011/04/13)

Renin inhibitors, which are spirocyclic piperidine amides, of structural formula (I) and pharmaceutical compositions thereof useful in the treatment of cardiovascular diseases and renal insufficiency, wherein n, for each instance in which it occurs, is independently 0, 1, or 2; R1 is hydrogen, C1-6 -alkyl or C3-6 -cycloalkyl, wherein said C1-6 -alkyl or C3-6 -cycloalkyl group can be independently substituted with 1-3 halogens; A is (i) a five- or six-membered saturated or unsaturated heterocyclic or carbocyclic monocyclic ring or (ii) a five- or six-membered saturated or unsaturated heterocyclic or carbocyclic ring which is fused to another five- or six-membered saturated or unsaturated heterocyclic or carbocyclic ring, V is a bond or -(C=O)-, -CH(OH)-, -CH2- or =CH-; U is a bond or -CH2-, or for the case when V is =CH-, U is -CH=; X is =CH-, =CF-, =C(OR3)-, or -C=O-; and Y is =CH-, =CF-, =N-, or for the case when X is -C=O-, Y is -N(R3)-.

3,4 - SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS

-

Page/Page column 30, (2010/06/22)

The present invention relates to 3,4-substituted piperidinyl - based renin inhibitor compounds bearing at 4-position oxopyridine or lsoquinolone and having the formula (I): wherein., S is Formula (IIa) or Formula (IIb). The invention further relates to pharmaceutical compositions containing said compounds, as well as their use in treating cardiovascular events and renal insufficiency.

RENIN INHIBITORS

-

Page/Page column 23, (2009/07/17)

The present invention relates to piperidinyl-based renin inhibitor compounds having the formula containing amino-terminal groups, and their use in treating cardiovascular events and renal insufficiency.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1160185-08-9